Zuanic & Associates is a distinguished boutique firm specializing in equity research, consulting, and advisory services tailored to emerging consumer sectors. Under the leadership of renowned Wall Street analyst Pablo Zuanic, the firm provides insightful coverage of companies in North America and internationally, delivering both thematic and stock-specific research. Their publications frequently attract attention from major business wires, trade journals, and social media platforms, highlighting the firm's influence in the market. Committed to producing thoughtful and comprehensive research, Zuanic & Associates empowers clients to make informed investment decisions. Furthermore, they offer customized consulting and research advisory services designed to address the unique needs of each client, ensuring they receive the most relevant insights for their investment strategies.
Please click here to visit our new website www.zuanicassociates.com
First of all
Experienced Equity Analyst
Pablo Zuanic has over 20 years of experience covering stocks in the U.S., Europe, LatAm, and Asia across sub-sectors. He combines his strategic mindset from his management consulting background with his equity research approach.
Not to mention
Cannabis and Psychedelics Sector Expert
Pablo Zuanic is a well-known and highly-rated equity analyst, most recently following the cannabis and psychedelics sector. Over the past four years, he launched coverage of over 35 companies (MSOs, LPs, CBS, MJ ancillary, mental health clinics), kept close track of sectoral trends, and followed the reform process in the U.S. and elsewhere.
And let's not forget
Short-term Consulting and Research Advisory Projects
Pablo Zuanic is available for short-term consulting and research advisory projects. At various points in his career, Pablo was II ranked and called as an expert witness in industry investigations. Prior employers include JP Morgan, Barings, and Cantor Fitzgerald.
About us
Zuanic & Associates is a consulting and research advisory firm led by renowned Wall Street equity analyst Pablo Zuanic. The firm is also in the process of launching a comprehensive cannabis/ psychedelics research subscription service aimed at institutional investors and corporations (in-depth, data-driven, thorough, and thoughtful). Contact us today for consulting ad research advisory services.